Clinical Trial Update: Cost Utility Analysis in Recurrent Ovarian Cancer

View source ↗

Summary

A cost-utility analysis clinical trial in recurrent ovarian cancer sponsored by MD Anderson Cancer Center has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Status: WITHDRAWN